Ernesto Bertarelli (#275)
- $ 12 B
- Biotech, investments
- Switzerland
- M
- 60 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Ernesto Bertarelli inherited biotech giant Serono, maker of the multiple sclerosis drug Rebif, following his father's death in 1998. With his sister Dona, he expanded the company to $2.4 billion in revenues before selling it to Merck for over $13 billion in 2007. Ernesto and Dona co-chair the Bertarelli Foundation, which focuses on marine conservation and life sciences research. The family's B-Flexion Group has investments ranging from commercial real estate in London to drug companies. He also owns the superyacht Vava II.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Ernesto Bertarelli’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Ernesto Bertarelli’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $11.6B
(May 4, 2026)
© Iconic Billionaires